InsiderClue
Insiders · Profile

Ryan Charles S.

PRESIDENT at Quince Therapeutics · Director at BioRestorative Therapies. Filing since 8 May 2015. CIK 0001624830

QNCX Quince Therapeutics, Inc. PRESIDENT · 1 trade BRTX BioRestorative Therapies, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX Quince Therapeutics, Inc.
20 Aug 2024
PRESIDENT
Bought
48,387
$31.45K
65.3%
BRTX BioRestorative Therapies, Inc.
7 Dec 2015
Director
Bought
6,250
$25.00K
62.5%
BRTX BioRestorative Therapies, Inc.
8 May 2015
Director
Bought
200,000
$50.00K
opened
3 decisions on file.